Oncology 1 Flashcards
Dosing Consideration for Select Highly Toxic Drugs
Bleomycin - lifetime cumulative dose 400 units = pulmonary toxicity
Doxorubicin - lifetime cumulative dose 450-550 mg = cardiotoxicity
Cisplatin - dose per cycle not to exceed 100 mg = nephrotoxicity
Vincristine - single dose “capped” at 2 mg = neuropathy
Dexrazoxane
Zinecard - prophylaxis to prevent cardiomyopathy
Totect - treatment for extravasation
Filgrastim
Neuopogen
Pegfilgrastim
Neulasta
Epoetin alfa
Epogen, Procrit
Darbepoetin alfa
Aranesp
Aprepitant
Emend - capsule, suspension, injection
Fosaprepitant
Emend - Injection
Ondansetron
Zofran, Zuplenz film
Granisetron
Sancuso
Palonosetron
Aloxi
Dexamethasone
Decadron
Prochlorperazine
Compazine
Promethazine
Phenergan - do not use in children < 2 years; do not give via intra-arterial or SC administration; IV route can cause serious tissue injury if extravasation occurs
Metochlopramide
Reglan - tardive dyskinesia that can be irreversible
Olanzapine
Zyprexa
Dronabinol
Marinol
Capsules: C-III
Solution: C-II
Refrigerate
Nabilone
Cesamet
C-II
Lorazepam
Ativan
C-IV
Myelosuppression
Almost all classic chemotherapy drugs, except:
Asparaginase, bleomycin, vincristine
Nausea and vomiting
Cisplatin, cyclophosphamide, ifosfamide
Mucositis
Fluorouracil and methotrexate
Diarrhea
Irinotecan, capecitabine, fluorouracil and methotrexate
Constipation
Vincristine
Xerostomia
Caused by radiation therapy to the head or neck regions
Cardiotoxicity
Cardiomyopathy: anthracyclines
QT prolongation: arsenic trioxide, many TKIs
Pulmonary Toxicity
Pulmonary fibrosis: bleomycin, busulfan, carmustine, lomustine
Pneumonitis: immune therapy MAbs
Hepatotoxicity
Antiandrogens (bicalutamide, flutamide, nilutamide)
Nephrotoxicity
Cisplatin, methotrexate
Hemorrhagic cystitis
Ifosfamide (all doses), cyclophosphamide (higher doses)
Neuropathy
Vinca alkaloids, platinum, taxanes
Thromboembolic risk
Aromatase inhibitors (anastrozole, letrozole) SERMs (tamoxifen, raloxifene)